MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway
Zhiyu Li(Wuhan University), Shengrong Sun(Wuhan University)
Cited by 32
Related Papers
Lipid-associated macrophages in the tumor-adipose microenvironment facilitate breast cancer progression
|OncoImmunology|2022|163
Cell Surface GRP78 Accelerated Breast Cancer Cell Proliferation and Migration by Activating STAT3
|PLoS ONE|2015|68
Metabolic regulation in the immune response to cancer
|Cancer Communications|2021|56
Knockdown of B7H6 inhibits tumor progression in triple‑negative breast cancer
|Oncology Letters|2018|22
UNBS5162 induces growth inhibition and apoptosis via inhibiting PI3K/AKT/mTOR pathway in triple negative breast cancer MDA‑MB‑231 cells
|Experimental and Therapeutic Medicine|2018|13